limiting the use of OTC cough and cold medicines in young children

New evidence verifies the benefit of limiting the use of OTC cough and cold medicines in young children.

The infant versions are no longer marketed...and the remaining children's products are no longer labeled for children under age 4 or 6.

Now a new report suggests this is making a big difference.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote